Denileukin diftitox for the treatment of steroid-resistant acute graft-versus-host disease
Open Access
- 1 March 2005
- journal article
- clinical trial
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 11 (3) , 188-193
- https://doi.org/10.1016/j.bbmt.2004.11.022
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantationTransplantation and Cellular Therapy, 2004
- Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: Comparison of grading systemsTransplantation and Cellular Therapy, 2002
- The IL-2/IL-2 receptor system: A current overviewCell, 1993
- A retrospective analysis of therapy for acute graft-versus-host disease: initial treatmentBlood, 1990
- Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcomeBlood, 1990
- The Multichain Interleukin 2 ReceptorPublished by American Medical Association (AMA) ,1990
- A possible role for Na+,K+-ATPase in regulating ATP-dependent endosome acidification.Proceedings of the National Academy of Sciences, 1989
- Internalization of interleukin 2 is mediated by the beta chain of the high-affinity interleukin 2 receptor.The Journal of Experimental Medicine, 1987
- The Structure, Function, and Expression of Interleukin-2 Receptors on Normal and Malignant LymphocytesScience, 1986
- Diphtheria toxin fragment forms large pores in phospholipid bilayer membranes.Proceedings of the National Academy of Sciences, 1981